Retinal nerve fiber layer thickness measured by optical coherence tomography in patients with schizophrenia: A short report

European Journal of Psychiatry

Volumn 24, Issue 4, 2010, Pages 227-235

  Ascaso, Francisco J ^a,b,c   Cabezón, Laura ^a   Quintanilla, Miguel Ángel ^a   Galve, Leticia Gutiérrez ^b,c   López Antón, Raúl ^d   Cristóbal, José A ^a,c   Lobo, Antonio ^a,b,c,d  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b Institute (I+CS)   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Macular volume; Optical coherence tomography; Retinal nerve fiber layer thickness; Schizophrenia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; PRESSURE MEASUREMENT; REFRACTION ERROR; RETINA MACULA LUTEA; RETINAL NERVE FIBER LAYER THICKNESS; SCHIZOPHRENIA; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

EID: 79952348769     PISSN: 02136163     EISSN: None     Source Type: Journal    
DOI: 10.4321/S0213-61632010000400005     Document Type: Article

References (54)

1. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. Systematic review and meta-analyisis of magnetic resonance imaging studies. Br J Psychiatry 2006; 188: 510-518.
2. Siever LJ, Davis KL. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am J Psychiatry 2004; 161: 398-413.
3. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a metaanalysis of voxel-based morphometry studies. Am J Psychiatry 2005; 162: 2233-2245.
4. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 1998; 55: 433-440.
5. Konick LC, Friedman L. Meta-analysis of thalamic size in schizophrenia. Biol Psychiatr 2001; 49: 28-38.
6. Baiano M, David A, Versace A, Churchill R, Balestrieri M, Brambilla P. Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophr Res 2007; 93: 1-12.
7. Woodruff PW, McManus IC, David AS. Meta-analysis of corpus callosum in schizophrenia. J Neurol Neurosurg Psychiatry 1995; 58: 457-461.
8. Arnone D, Mcintosh AM, Tan GMY, Ebmeier KP. Meta-analysis of magnetic resonance imaging studies of the corpus callosum in schizophrenia. Schizophr Res 2008; 101: 124-132.
9. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000; 157: 16-25.
10. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation metaanalysis. Am J Psychiatry 2008; 165: 1015-1023.
11. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res 2001; 49: 1-52.
12. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 1998; 172: 110-120.
13. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, et al. MRI anatomy of schizophrenia. Biol Psychiatry 1999; 45:1099-1119.
14. Ward KE, Friedman L, Wise A, Schulz SC. Metaanalysis of brain and cranial size in schizophrenia. Schizophr Res 1996; 22: 197-213.
15. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, Mcintosh AM. Magnetic resonance imaging studies in bipolar and schizophrenia: meta-analysis. Br J Psychiatry 2009; 195: 194-201.
16. Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol 2004; 137: 156-169.
17. Hassenstein A, Spital G, Scholz F, Henschel A, Richard G, Pauleikhoff D. Optical coherence tomography for macula diagnostics. Review of methods and standardized application concentrating on diagnostic and therapy control of age-related macula degeneration. Ophthalmologe 2009; 106: 116-126.
18. Bowd C, Zangwill LM, Blumenthal EZ, Vasile C, Boehm AG, Gokhale PA, et al. Imaging of the optic disc and retinal nerve fiber layer: effects of age, optic disc area, refractive error and gender. J Opt Soc Am A Opt Image Sci Vis 2002; 19: 197-207.
19. Kanamori A, Escano M-F, Eno A, Nakamura M, Maeda H, Seya R, et al. Evaluation of the effect of aging on retinal nerve fiber layer thickness measured by optical coherence tomography. Ophthalmologica 2003; 217: 273-278.
20. Varma R, Bazzaz S, Iai M. Optical tomographymeasured retinal nerve fiber layer thickness in normal latinos. Invest Ophthalmol Vis Sci 2003; 44: 3369-3373.
21. Lamirel C, Newman N, Biousse V. The use of optical coherence tomography in Neurology. Rev Neurol Dis 2009; 6(4): E105-E120.
22. Sergott RC, Frohman E, Glanzman R, Al-Sabbagh A. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci 2007;263: 3-14.
23. Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 2008; 4: 664-675.
24. Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999; 40: 2520-2527.
25. Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113: 324-332.
26. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, García-Layana A, Bejarano B, Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007; 68: 1488-1494.
27. Henderson AP, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, Plant GT, et al. An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2008; 131: 277-287.
28. Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, Francis GS, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997; 41: 385-391.
29. De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998; 121: 1469-1477.
30. Thrower BW. Clinically isolated syndromes: predicting and delaying multiple sclerosis. Neurology 2007; 68: S12-S15.
31. Frisen L, Hoyt WF. Insidious atrophy of retinal nerve fibers in multiple sclerosis. Funduscopic identification in patients with and without visual complaints. Arch Ophthalmol 1974; 92: 91-97.
32. Ikuta F, Zimmerman HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 1976; 26: 26-28.
33. Toussaint D, Perier O, Verstappen A, Bervoets S. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 1983; 3: 211-220.
34. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 2001; 112: 1860-1867.
35. Iseri PK, Altinas O, Tokay T, Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 2006; 26: 18-24.
36. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2007; 420: 97-99.
37. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 2007; 48: 2285-2289.
38. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 2004; 44: 2793-2797.
39. Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 2008; 116: 137-146.
40. Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, et al. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 2009; 127: 737-741.
41. Shenton ME, Whitford TJ, Kubicki M. Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci 2010; 12: 317-332.
42. Di X, Chan RC, Gong QY. White matter reduction in patients with schizophrenia as revealed by voxel-based morphometry: an activation likelihood estimation metaanalysis. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 1390-1394.
43. Suddath RL, Casanova MF, Goldberg TE, Daniel DG, Kelsoe JR Jr, Weinberger DR. Temporal lobe pathology in schizophrenia: a quantitativemagnetic resonance imaging study. Am J Psychiatry 1989; 146: 464-472.
44. Davidson LL, Heinrichs RW. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Res 2003; 122: 69-87.
45. Zakzanis KK, Heinrichs RW. Schizophrenia and the frontal brain: a quantitative review. J Int Neuropsychol Soc 1999; 5: 556-566.
46. Howard MA, Roberts N, García-Fiñana M, Cowell PE. Volume estimation of prefrontal cortical subfields using MRI and stereology. Brain Res Brain Res Protoc 2003; 10(3): 125-138.
47. MacFall JR, Payne ME, Krishnan KRR. MR scanner geometry changes: phantom measurements compared to intracranial contents calculations. Proceedings of the International Society for Magnetic Resonance in Medicine 2004; 11: 2182.
48. DeLisi LE, Hoff AL, Schwart JE, Shields GW, Halthore SN, Gupta SM, et al. Brainmorphology in firstepisode schizophrenic-like psychotic patients: a quantitativemagnetic resonance imaging study. Biol Psychiatry 1991; 29: 159-175.
49. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994; 151:1430-1436.
50. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, et al. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 1998; 55(2):145-152.
51. Harrison PJ, Freemantle N, Geddes JR. Meta-analysis of brainweight in schizophrenia. Schizophr Res 2003; 64: 25-34.
52. Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 2008; 4: 664-675.
53. Gramer E, Dirmeyer M. Optical coherence tomography (OCT) to measure nerve fiber layer thickness in normal eyes. Invest Ophthalmol Vis Sci 1998; 39(4): S933(ARVO abstract no. 4296).
54. Maynard TM, Sikich L, Lieberman JA, LaMantia AS. Neural development, cell-cell signaling, and the 'twohit' hypothesis of schizophrenia. Schizophr Bull 2001; 27: 457-476.